The "Viral Vector Vaccines - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Viral Vector Vaccines was estimated at US$773.4 Million in ...
This letter to the editor presents an in-depth overview of the current state of Nipah virus (NiV) vaccine development, highlighting both scientific advancements and critical challenges that still ...
Live attenuated vaccines mimic natural infections, providing strong immunity but require refrigeration and caution for immunocompromised individuals. Subunit vaccines offer targeted immunity without ...
Hosted on MSN
Different types of COVID-19 vaccines: How they work
COVID-19 vaccines lower the risk of getting sick, seriously ill or dying from the disease. But how do the different types of COVID-19 vaccines work? Each COVID-19 vaccine causes the immune system to ...
Univercells Technologies agreed to collaborate with Repligen to integrate real-time monitoring capabilities and enhance the development and manufacturing of viral vectors and vaccines. Repligen’s ...
A groundbreaking study explains why certain COVID-19 vaccines caused dangerous blood clots, hemorrhages and VITT syndrome, resulting in the deaths of around 200 people in Europe.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results